Australia's most trusted
source of pharma news
Sunday, 05 October 2025
Posted 3 October 2025 PM
Australia's medicines access system is at breaking point with the third company in as many months walking away from the PBS - and our readers wanted to know more, making this our top story of the week.
Pfizer announced it would abandon efforts to have its severe atopic dermatitis treatment Cibinqo listed on the PBS after it became clear that low pricing and an unreasonable risk sharing agreement on offer from the government made it commercially unsustainable.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.